Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Poseida Therapeutics Inc have a median target of 12.00, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a 289.61% increase from the last price of 3.08.
High | 549.4% | 20.00 |
Med | 289.6% | 12.00 |
Low | 224.7% | 10.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 05, 2025.
Average growth rate | +0.75% |
Average growth rate | +15.37% |
More ▼
Revenue history & estimates in USD
Average growth rate | +87.10% |
Average growth rate | +133.66% |
More ▼